Optimal drug combinations to combat regional tuberculosis isolates
College of Medicine & Dentistry; Australian Institute of Tropical Health and Medicine
Drug resistance in Mycobacterium tuberculosis (Mtb) may prove an insurmountable hurdle in TB control. After a decades long wait, new drugs have finally reached the market and these must be used judiciously in order to prevent resistance emergence and failure of therapy. New data on clinical impact and in vitro efficacy our now available, and these data will be modelled in this project to ascertain the impact of different combinations of anti-mycobacterial agents.
Has a background in mathematics or other quantitative discipline
Has an interest in pharmacology or applying mathematics to a pkpd model
Has an interest in international health